Transactions
6
Insider / Ulta Beauty, Inc.
DelOrefice Christopher
Chief Financial Officer at Ulta Beauty, Inc.
- Company
- Ulta Beauty, Inc.
- First filing on record
- December 1, 2025
- Latest trade on record
- March 31, 2026
- SEC filings
- EDGAR ↗
DelOrefice Christopher, Chief Financial Officer at Ulta Beauty, Inc., has disclosed 6 transactions in ULTA, BDX since December 1, 2025: 0 purchases (0 open-market buys) and 1 sale, worth about $0 at the reported prices. The latest was filed April 2, 2026, 2 days after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
1
Avg. disclosure lag
2.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months DelOrefice Christopher made no purchases and 1 sale worth $0, plus 5 other transactions. Dot size is the dollar amount.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 5 | 30,062 | — |
| F | Shares withheld for tax | 1 | 4,245 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 0 |
| 2025 | 4 | 0 | 1 · $0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ULTA | Other A | March 31, 2026 | April 2, 2026 | 2d | 14,363 | — | — | derivative | Form 4 ↗ | |
| ULTA | Other A | March 31, 2026 | April 2, 2026 | 2d | 4,219 | — | — | Form 4 ↗ | ||
| ULTA | Other A | December 9, 2025 | December 10, 2025 | 1d | 3,649 | — | — | Form 4 ↗ | ||
| ULTA | Other A | December 9, 2025 | December 10, 2025 | 1d | 1,825 | — | — | Form 4 ↗ | ||
| BDX | Sell F | November 26, 2025 | December 1, 2025 | 5d | 4,245 | — | — | late | Form 4 ↗ | |
| BDX | Other A | November 26, 2025 | December 1, 2025 | 5d | 6,006 | — | — | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 2, 2026 | Form 4 | 0000897069-26-000771 | 2 | published | EDGAR ↗ |
| December 10, 2025 | Form 4 | 0000897069-25-001790 | 2 | published | EDGAR ↗ |
| December 1, 2025 | Form 4 | 0001628280-25-054346 | 2 | published | EDGAR ↗ |
Other insiders at Ulta Beauty, Inc.
- GARCIA KELLY E Director 42 rows
- Halligan Catherine Ann Director 16 rows
- Feld Michael EVP, Chief Revenue Officer 15 rows
- Garrison Michael David EVP & Pres Med.Essntl&BioPharm 11 rows
- Huffines Robert Luther Director 11 rows
- Polen Thomas E Jr Chairman, CEO and President 11 rows
- Steelman Kecia Director 9 rows
- Henderson Jeffrey William Director 7 rows
- MRKONIC GEORGE R JR Director 7 rows
- Brown William M Director 5 rows
Everyone on file, with contracts and lobbying under the company's name: Ulta Beauty, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 6 | December 1, 2025 | April 2, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.